Free Trial
Guggenheim

Guggenheim Analyst Recommendations & Stock Picks

View the latest stock recommendations issued by analysts at Guggenheim. This page tracks publicly reported analyst upgrades and downgrades, buy/hold/sell ratings, and price target changes for publicly traded companies. All data is compiled from credible public sources and updated regularly to reflect new insights from Guggenheim's equity research team. MarketBeat is not affiliated with or endorsed by Guggenheim.

Average Return
00.00% 12-Month ROI
Total Ratings
1,206 Last 12 Months
Buy Ratings
1,033 Last 12 Months
Sell Ratings
5 Last 12 Months
Companies Covered
415 Last 12 Months
MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
0 Results
CompanyCurrent PriceReport DateAnalystActionPrice TargetRating12-Month Recommendation ROIDetails
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
$145.51
+0.9%
10/6/2026Initiated Coverage$207.00BuyView details for Guggenheim rating of Neurocrine Biosciences (NASDAQ:NBIX) on 10/6/2026
Xenon Pharmaceuticals Inc. stock logo
XENE
Xenon Pharmaceuticals
$36.57
-2.7%
10/6/2026Initiated Coverage$73.00BuyView details for Guggenheim rating of Xenon Pharmaceuticals (NASDAQ:XENE) on 10/6/2026
Yum! Brands, Inc. stock logo
YUM
Yum! Brands
$139.89
+2.1%
10/6/2026Lower Price Target$180.00 ➝ $155.00BuyView details for Guggenheim rating of Yum! Brands (NYSE:YUM) on 10/6/2026
Rapport Therapeutics, Inc. stock logo
RAPP
Rapport Therapeutics
$31.15
-3.2%
10/5/2026Initiated Coverage$65.00BuyView details for Guggenheim rating of Rapport Therapeutics (NASDAQ:RAPP) on 10/5/2026
Maplight Therapeutics, Inc. stock logo
MPLT
Maplight Therapeutics
$9.69
+4.5%
10/5/2026Initiated CoverageNeutralView details for Guggenheim rating of Maplight Therapeutics (NASDAQ:MPLT) on 10/5/2026
LB Pharmaceuticals Inc stock logo
LBRX
LB Pharmaceuticals
$34.26
-1.0%
10/5/2026Initiated Coverage$80.00BuyView details for Guggenheim rating of LB Pharmaceuticals (NASDAQ:LBRX) on 10/5/2026
Rapport Therapeutics, Inc. stock logo
RAPP
Rapport Therapeutics
$31.15
-3.2%
10/5/2026 Set Price Target$65.00BuyView details for Guggenheim rating of Rapport Therapeutics (NASDAQ:RAPP) on 10/5/2026
Genmab A/S Sponsored ADR stock logo
GMAB
Genmab A/S
$37.80
-1.8%
10/5/2026Boost Price Target$45.00 ➝ $54.00BuyView details for Guggenheim rating of Genmab A/S (NASDAQ:GMAB) on 10/5/2026
Vaxcyte, Inc. stock logo
PCVX
Vaxcyte
$66.70
-9.6%
10/5/2026Boost Price Target$116.00 ➝ $125.00BuyView details for Guggenheim rating of Vaxcyte (NASDAQ:PCVX) on 10/5/2026
McDonald's Corporation stock logo
MCD
McDonald's
$232.69
-0.2%
10/5/2026Lower Price Target$290.00 ➝ $250.00NeutralView details for Guggenheim rating of McDonald’s (NYSE:MCD) on 10/5/2026
Ovid Therapeutics stock logo
OVID
Ovid Therapeutics
$2.37
+1.3%
10/5/2026Initiated Coverage$7.00BuyView details for Guggenheim rating of Ovid Therapeutics (NASDAQ:OVID) on 10/5/2026
Yesway, Inc. stock logo
YSWY
Yesway
$20.25
+0.9%
10/5/2026Reiterated Rating$32.00BuyView details for Guggenheim rating of Yesway (NASDAQ:YSWY) on 10/5/2026
Foghorn Therapeutics Inc. stock logo
FHTX
Foghorn Therapeutics
$1.97
-1.5%
10/2/2026Lower Price Target$12.00 ➝ $5.00BuyView details for Guggenheim rating of Foghorn Therapeutics (NASDAQ:FHTX) on 10/2/2026
Sagimet Biosciences Inc. stock logo
SGMT
Sagimet Biosciences
$8.76
-3.0%
10/2/2026Boost Price Target$25.00 ➝ $26.00BuyView details for Guggenheim rating of Sagimet Biosciences (NASDAQ:SGMT) on 10/2/2026
MBX Biosciences, Inc. stock logo
MBX
MBX Biosciences
$56.92
-2.8%
10/2/2026Boost Price Target$88.00 ➝ $150.00BuyView details for Guggenheim rating of MBX Biosciences (NASDAQ:MBX) on 10/2/2026
NIKE, Inc. stock logo
NKE
NIKE
$34.60
+1.9%
10/2/2026Reiterated Rating$60.00 ➝ $50.00BuyView details for Guggenheim rating of NIKE (NYSE:NKE) on 10/2/2026
Foghorn Therapeutics Inc. stock logo
FHTX
Foghorn Therapeutics
$1.97
-1.5%
10/2/2026Lower Price Target$12.00 ➝ $5.00BuyView details for Guggenheim rating of Foghorn Therapeutics (NASDAQ:FHTX) on 10/2/2026
Accenture PLC stock logo
ACN
Accenture
$193.67
-0.7%
10/2/2026Reiterated RatingNeutralView details for Guggenheim rating of Accenture (NYSE:ACN) on 10/2/2026
Waters Corporation stock logo
WAT
Waters
$436.18
-0.9%
10/1/2026Boost Price Target$440.00 ➝ $490.00BuyView details for Guggenheim rating of Waters (NYSE:WAT) on 10/1/2026
Twist Bioscience Corporation stock logo
TWST
Twist Bioscience
$166.97
-18.6%
10/1/2026Boost Price Target$107.00 ➝ $212.00BuyView details for Guggenheim rating of Twist Bioscience (NASDAQ:TWST) on 10/1/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
$71.98
-13.8%
10/1/2026Boost Price Target$65.00 ➝ $92.00BuyView details for Guggenheim rating of Tempus AI (NASDAQ:TEM) on 10/1/2026
Natera, Inc. stock logo
NTRA
Natera
$400.65
-5.9%
10/1/2026Boost Price Target$360.00 ➝ $475.00BuyView details for Guggenheim rating of Natera (NASDAQ:NTRA) on 10/1/2026
Illumina, Inc. stock logo
ILMN
Illumina
$273.54
-6.9%
10/1/2026Boost Price Target$226.00 ➝ $305.00BuyView details for Guggenheim rating of Illumina (NASDAQ:ILMN) on 10/1/2026
Guardant Health, Inc. stock logo
GH
Guardant Health
$170.69
-8.8%
10/1/2026Boost Price Target$190.00 ➝ $200.00BuyView details for Guggenheim rating of Guardant Health (NASDAQ:GH) on 10/1/2026
Danaher Corporation stock logo
DHR
Danaher
$215.49
-2.6%
10/1/2026Boost Price Target$200.00 ➝ $250.00BuyView details for Guggenheim rating of Danaher (NYSE:DHR) on 10/1/2026
CryoPort, Inc. stock logo
CYRX
CryoPort
$17.80
-1.9%
10/1/2026Boost Price Target$16.00 ➝ $19.00BuyView details for Guggenheim rating of CryoPort (NASDAQ:CYRX) on 10/1/2026
Bruker Corporation stock logo
BRKR
Bruker
$60.50
-5.3%
10/1/2026Boost Price Target$70.00 ➝ $72.00BuyView details for Guggenheim rating of Bruker (NASDAQ:BRKR) on 10/1/2026
Billiontoone, Inc. stock logo
BLLN
Billiontoone
$99.94
-8.4%
10/1/2026Boost Price Target$125.00 ➝ $128.00BuyView details for Guggenheim rating of Billiontoone (NASDAQ:BLLN) on 10/1/2026
Adaptive Biotechnologies Corporation stock logo
ADPT
Adaptive Biotechnologies
$26.90
-9.9%
10/1/2026Boost Price Target$25.00 ➝ $32.00BuyView details for Guggenheim rating of Adaptive Biotechnologies (NASDAQ:ADPT) on 10/1/2026
Netflix, Inc. stock logo
NFLX
Netflix
$68.69
+1.8%
10/1/2026Reiterated Rating$75.00 ➝ $80.00BuyView details for Guggenheim rating of Netflix (NASDAQ:NFLX) on 10/1/2026
GRAIL, Inc. stock logo
GRAL
GRAIL
$137.28
-10.9%
10/1/2026Boost Price Target$75.00 ➝ $155.00BuyView details for Guggenheim rating of GRAIL (NASDAQ:GRAL) on 10/1/2026
GeneDx Holdings Corp. stock logo
WGS
GeneDx
$71.52
-6.2%
10/1/2026Boost Price Target$74.00 ➝ $83.00BuyView details for Guggenheim rating of GeneDx (NASDAQ:WGS) on 10/1/2026
DICK'S Sporting Goods, Inc. stock logo
DKS
DICK'S Sporting Goods
$134.64
-1.8%
9/30/2026 Reiterated RatingNeutralView details for Guggenheim rating of DICK’S Sporting Goods (NYSE:DKS) on 9/30/2026
Neogen Corporation stock logo
NEOG
Neogen
$11.96
-8.1%
9/30/2026Reiterated Rating$12.00 ➝ $14.00BuyView details for Guggenheim rating of Neogen (NASDAQ:NEOG) on 9/30/2026
Zenas BioPharma, Inc. stock logo
ZBIO
Zenas BioPharma
$26.94
-3.2%
9/30/2026Reiterated Rating$55.00BuyView details for Guggenheim rating of Zenas BioPharma (NASDAQ:ZBIO) on 9/30/2026
BWX Technologies, Inc. stock logo
BWXT
BWX Technologies
$145.83
+7.7%
9/30/2026Reiterated Rating$192.00BuyView details for Guggenheim rating of BWX Technologies (NYSE:BWXT) on 9/30/2026
MongoDB, Inc. stock logo
MDB
MongoDB
$360.71
+0.4%
9/29/2026Reiterated Rating$560.00BuyView details for Guggenheim rating of MongoDB (NASDAQ:MDB) on 9/29/2026
AAR Corp. stock logo
AIR
AAR
$103.98
+1.7%
9/29/2026Reiterated RatingNeutralView details for Guggenheim rating of AAR (NYSE:AIR) on 9/29/2026
Warner Music Group Corp. stock logo
WMG
Warner Music Group
$27.61
-0.1%
9/29/2026Reiterated Rating$36.00BuyView details for Guggenheim rating of Warner Music Group (NASDAQ:WMG) on 9/29/2026
Costco Wholesale Corporation stock logo
COST
Costco Wholesale
$935.85
+1.3%
9/28/2026 Reiterated RatingNeutralView details for Guggenheim rating of Costco Wholesale (NASDAQ:COST) on 9/28/2026
Trump's New Dollar (Ad)

Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.tc pixel

Watch the free briefing and see the three steps to prepare today
The Walt Disney Company stock logo
DIS
Walt Disney
$103.92
+0.3%
9/28/2026Reiterated Rating$120.00BuyView details for Guggenheim rating of Walt Disney (NYSE:DIS) on 9/28/2026
First Solar, Inc. stock logo
FSLR
First Solar
$179.80
+2.1%
9/28/2026Reiterated RatingBuyView details for Guggenheim rating of First Solar (NASDAQ:FSLR) on 9/28/2026
Absci Corporation stock logo
ABSI
Absci
$10.27
-10.9%
9/28/2026Reiterated RatingBuyView details for Guggenheim rating of Absci (NASDAQ:ABSI) on 9/28/2026
Cyclerion Therapeutics, Inc. stock logo
KRSA
Cyclerion Therapeutics
$31.77
+3.4%
9/28/2026Initiated Coverage$70.00BuyView details for Guggenheim rating of Cyclerion Therapeutics (NASDAQ:KRSA) on 9/28/2026
Zscaler, Inc. stock logo
ZS
Zscaler
$212.25
+5.2%
9/25/2026Reiterated RatingBuyView details for Guggenheim rating of Zscaler (NASDAQ:ZS) on 9/25/2026
Akamai Technologies, Inc. stock logo
AKAM
Akamai Technologies
$108.62
+0.6%
9/25/2026Boost Price Target$190.00 ➝ $225.00BuyView details for Guggenheim rating of Akamai Technologies (NASDAQ:AKAM) on 9/25/2026
Damora Therapeutics, Inc. Common Stock stock logo
DMRA
Damora Therapeutics, Inc. Common Stock
$19.55
-3.3%
9/25/2026Boost Price Target$40.00 ➝ $60.00BuyView details for Guggenheim rating of Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA) on 9/25/2026
Darden Restaurants, Inc. stock logo
DRI
Darden Restaurants
$203.37
+1.8%
9/25/2026Reiterated Rating$235.00BuyView details for Guggenheim rating of Darden Restaurants (NYSE:DRI) on 9/25/2026
Entera Bio Ltd. stock logo
ENTX
Entera Bio
$2.53
-3.4%
9/24/2026Initiated Coverage$11.00BuyView details for Guggenheim rating of Entera Bio (NASDAQ:ENTX) on 9/24/2026
Okta, Inc. stock logo
OKTA
Okta
$218.67
+0.2%
9/24/2026Boost Price Target$188.00 ➝ $227.00BuyView details for Guggenheim rating of Okta (NASDAQ:OKTA) on 9/24/2026
Travere Therapeutics, Inc. stock logo
TVTX
Travere Therapeutics
$55.98
-2.9%
9/24/2026Boost Price Target$75.00 ➝ $89.00BuyView details for Guggenheim rating of Travere Therapeutics (NASDAQ:TVTX) on 9/24/2026
Entera Bio Ltd. stock logo
ENTX
Entera Bio
$2.53
-3.4%
9/24/2026UpgradeStrong-BuyView details for Guggenheim rating of Entera Bio (NASDAQ:ENTX) on 9/24/2026
Everpure, Inc. stock logo
P
Everpure
$147.03
+2.2%
9/24/2026Reiterated Rating$150.00BuyView details for Guggenheim rating of Everpure (NYSE:P) on 9/24/2026
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
$4.27
-2.5%
9/23/2026 Set Price Target$12.00View details for Guggenheim rating of TriSalus Life Sciences (NASDAQ:TLSI) on 9/23/2026
Domino's Pizza Inc stock logo
DPZ
Domino's Pizza
$302.87
+1.9%
9/23/2026Lower Price Target$440.00 ➝ $325.00NeutralView details for Guggenheim rating of Domino’s Pizza (NASDAQ:DPZ) on 9/23/2026
AutoZone, Inc. stock logo
AZO
AutoZone
$2,900.90
+3.3%
9/23/2026Lower Price Target$4,000.00 ➝ $3,750.00BuyView details for Guggenheim rating of AutoZone (NYSE:AZO) on 9/23/2026
Compass Therapeutics, Inc. stock logo
CMPX
Compass Therapeutics
$1.00
+3.9%
9/23/2026Lower Price Target$4.00BuyView details for Guggenheim rating of Compass Therapeutics (NASDAQ:CMPX) on 9/23/2026
Editas Medicine, Inc. stock logo
EDIT
Editas Medicine
$2.73
-2.2%
9/23/2026Upgrade$5.00Neutral ➝ BuyView details for Guggenheim rating of Editas Medicine (NASDAQ:EDIT) on 9/23/2026
Fox Corporation stock logo
FOXA
FOX
$62.08
-2.0%
9/23/2026Reiterated Rating$85.00BuyView details for Guggenheim rating of FOX (NASDAQ:FOXA) on 9/23/2026
BlossomHill Therapeutics, Inc. stock logo
BLSM
BlossomHill Therapeutics
$17.29
-13.3%
9/21/2026Boost Price Target$30.00 ➝ $40.00BuyView details for Guggenheim rating of BlossomHill Therapeutics (NASDAQ:BLSM) on 9/21/2026
Lowe's Companies, Inc. stock logo
LOW
Lowe's Companies
$183.80
+2.4%
9/21/2026Reiterated Rating$275.00BuyView details for Guggenheim rating of Lowe’s Companies (NYSE:LOW) on 9/21/2026
Autodesk, Inc. stock logo
ADSK
Autodesk
$231.28
+4.4%
9/21/2026Reiterated Rating$283.00BuyView details for Guggenheim rating of Autodesk (NASDAQ:ADSK) on 9/21/2026
Lowe's Companies, Inc. stock logo
LOW
Lowe's Companies
$183.80
+2.4%
9/21/2026Reiterated Rating$275.00BuyView details for Guggenheim rating of Lowe’s Companies (NYSE:LOW) on 9/21/2026
Restaurant Brands International Inc. stock logo
QSR
Restaurant Brands International
$70.28
+0.6%
9/18/2026Boost Price Target$85.00 ➝ $86.00BuyView details for Guggenheim rating of Restaurant Brands International (NYSE:QSR) on 9/18/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$1,157.61
+1.3%
9/18/2026Boost Price Target$1,273.00 ➝ $1,284.00BuyView details for Guggenheim rating of Eli Lilly and Company (NYSE:LLY) on 9/18/2026
The Trade Desk stock logo
TTD
Trade Desk
$11.92
-0.5%
9/18/2026Reiterated Rating$12.00 ➝ $13.00NeutralView details for Guggenheim rating of Trade Desk (NASDAQ:TTD) on 9/18/2026
Accenture PLC stock logo
ACN
Accenture
$193.67
-0.7%
9/18/2026DowngradeBuy ➝ NeutralView details for Guggenheim rating of Accenture (NYSE:ACN) on 9/18/2026
Sirius XM Holdings Inc. stock logo
SIRI
Sirius XM
$26.36
+0.2%
9/17/2026Reiterated Rating$35.00 ➝ $37.00BuyView details for Guggenheim rating of Sirius XM (NASDAQ:SIRI) on 9/17/2026
Salesforce Inc. stock logo
CRM
Salesforce
$224.52
-2.3%
9/17/2026Boost Price Target$270.00 ➝ $300.00BuyView details for Guggenheim rating of Salesforce (NYSE:CRM) on 9/17/2026
Paychex, Inc. stock logo
PAYX
Paychex
$101.02
+1.2%
9/17/2026Reiterated RatingNeutralView details for Guggenheim rating of Paychex (NASDAQ:PAYX) on 9/17/2026
Lyft, Inc. stock logo
LYFT
Lyft
$15.76
+0.2%
9/17/2026Downgrade$22.00 ➝ $16.00Buy ➝ NeutralView details for Guggenheim rating of Lyft (NASDAQ:LYFT) on 9/17/2026
Dycom Industries, Inc. stock logo
DY
Dycom Industries
$290.76
+6.0%
9/17/2026Reiterated Rating$620.00BuyView details for Guggenheim rating of Dycom Industries (NYSE:DY) on 9/17/2026
Yesway, Inc. stock logo
YSWY
Yesway
$20.25
+0.9%
9/17/2026Reiterated Rating$32.00BuyView details for Guggenheim rating of Yesway (NASDAQ:YSWY) on 9/17/2026
Reddit Inc. stock logo
RDDT
Reddit
$148.80
-1.1%
9/16/2026 Reiterated RatingBuyView details for Guggenheim rating of Reddit (NYSE:RDDT) on 9/16/2026
Sysco Corporation stock logo
SYY
Sysco
$77.42
+1.4%
9/16/2026Reiterated Rating$90.00BuyView details for Guggenheim rating of Sysco (NYSE:SYY) on 9/16/2026
TRAX
First Tracks Biotherapeutics
$31.39
-4.8%
9/16/2026Initiated Coverage$100.00BuyView details for Guggenheim rating of First Tracks Biotherapeutics (NASDAQ:TRAX) on 9/16/2026
TRAX
First Tracks Biotherapeutics
$31.39
-4.8%
9/16/2026Initiated Coverage$100.00BuyView details for Guggenheim rating of First Tracks Biotherapeutics (NASDAQ:TRAX) on 9/16/2026
Sensei Biotherapeutics, Inc. stock logo
FTH
Sensei Biotherapeutics
$26.89
-0.8%
9/16/2026Initiated Coverage$70.00BuyView details for Guggenheim rating of Sensei Biotherapeutics (NASDAQ:FTH) on 9/16/2026
TRAX
First Tracks Biotherapeutics
$31.39
-4.8%
9/16/2026Initiated Coverage$100.00BuyView details for Guggenheim rating of First Tracks Biotherapeutics (NASDAQ:TRAX) on 9/16/2026
Ulta Beauty Inc. stock logo
ULTA
Ulta Beauty
$547.29
+0.8%
9/15/2026 Initiated CoverageBuyView details for Guggenheim rating of Ulta Beauty (NASDAQ:ULTA) on 9/15/2026
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
$44.00
+1.1%
9/15/2026Lower Price Target$89.00 ➝ $80.00BuyView details for Guggenheim rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 9/15/2026
Inventiva S.A. Sponsored ADR stock logo
IVA
Inventiva
$3.46
-0.6%
9/15/2026Boost Price Target$11.00 ➝ $14.00BuyView details for Guggenheim rating of Inventiva (NASDAQ:IVA) on 9/15/2026
The Wendy's Company stock logo
WEN
Wendy's
$6.16
+1.0%
9/15/2026 Reiterated RatingNeutralView details for Guggenheim rating of Wendy’s (NASDAQ:WEN) on 9/15/2026
The New York Times Company stock logo
NYT
New York Times
$64.12
+0.2%
9/15/2026Upgrade$70.00 ➝ $82.00Neutral ➝ BuyView details for Guggenheim rating of New York Times (NYSE:NYT) on 9/15/2026
Sensei Biotherapeutics, Inc. stock logo
FTH
Sensei Biotherapeutics
$26.89
-0.8%
9/15/2026UpgradeStrong-BuyView details for Guggenheim rating of Sensei Biotherapeutics (NASDAQ:FTH) on 9/15/2026
Moog Inc. stock logo
MOG.A
Moog
$376.31
-1.2%
9/15/2026Initiated CoverageNeutralView details for Guggenheim rating of Moog (NYSE:MOG.A) on 9/15/2026
Nanobiotix S.A. - Sponsored ADR stock logo
NBTX
Nanobiotix
$25.23
+0.5%
9/15/2026Initiated Coverage$64.00BuyView details for Guggenheim rating of Nanobiotix (NASDAQ:NBTX) on 9/15/2026
Transdigm Group Incorporated stock logo
TDG
Transdigm Group
$1,104.11
+1.0%
9/15/2026Initiated CoverageNeutralView details for Guggenheim rating of Transdigm Group (NYSE:TDG) on 9/15/2026
York Space Systems Inc. stock logo
YSS
York Space Systems
$8.03
-3.4%
9/14/2026Initiated CoverageNeutralView details for Guggenheim rating of York Space Systems (NYSE:YSS) on 9/14/2026
RBC Bearings Incorporated stock logo
RBC
RBC Bearings
$514.61
+0.4%
9/14/2026Initiated Coverage$600.00BuyView details for Guggenheim rating of RBC Bearings (NYSE:RBC) on 9/14/2026
My top 3 AI picks for the next decade (Ad)

Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up Amazon and Netflix under $3 per share in 2005. Now the chief investment strategist at The Oxford Club has identified three AI stocks he believes could be the most profitable investments of the next decade.tc pixel

Click here to get all three AI stock names from Alexander Green
Mercury Systems Inc stock logo
MRCY
Mercury Systems
$82.80
-0.2%
9/14/2026Initiated Coverage$115.00BuyView details for Guggenheim rating of Mercury Systems (NASDAQ:MRCY) on 9/14/2026
VSE Corporation stock logo
VSEC
VSE
$168.48
+0.2%
9/14/2026Initiated CoverageNeutralView details for Guggenheim rating of VSE (NASDAQ:VSEC) on 9/14/2026
Leonardo DRS, Inc. stock logo
DRS
Leonardo DRS
$36.78
+0.5%
9/14/2026Initiated Coverage$51.00BuyView details for Guggenheim rating of Leonardo DRS (NASDAQ:DRS) on 9/14/2026
L3Harris Technologies Inc stock logo
LHX
L3Harris Technologies
$237.70
+0.3%
9/14/2026Initiated Coverage$365.00BuyView details for Guggenheim rating of L3Harris Technologies (NYSE:LHX) on 9/14/2026
Karman Holdings Inc. stock logo
KRMN
Karman
$33.20
+0.6%
9/14/2026Initiated Coverage$63.00BuyView details for Guggenheim rating of Karman (NYSE:KRMN) on 9/14/2026
Heico Corporation stock logo
HEI
Heico
$303.33
+0.6%
9/14/2026Initiated CoverageNeutralView details for Guggenheim rating of Heico (NYSE:HEI) on 9/14/2026
Hexcel Corporation stock logo
HXL
Hexcel
$86.18
+0.3%
9/14/2026Initiated Coverage$120.00BuyView details for Guggenheim rating of Hexcel (NYSE:HXL) on 9/14/2026
AAR Corp. stock logo
AIR
AAR
$103.98
+1.7%
9/14/2026Initiated CoverageNeutralView details for Guggenheim rating of AAR (NYSE:AIR) on 9/14/2026
Woodward, Inc. stock logo
WWD
Woodward
$332.56
-0.1%
9/14/2026Initiated Coverage$404.00BuyView details for Guggenheim rating of Woodward (NASDAQ:WWD) on 9/14/2026
BWX Technologies, Inc. stock logo
BWXT
BWX Technologies
$145.83
+7.7%
9/14/2026Initiated Coverage$192.00BuyView details for Guggenheim rating of BWX Technologies (NYSE:BWXT) on 9/14/2026

MarketBeat's community ratings are surveys of what our community members think about Guggenheim and other research firms in the last 90 days. Vote "Outperform" if you believe Guggenheim's recommendations will outperform the broader market over the long term. Vote "Underperform" if you believe Guggenheim's recommendations will underperform the broader market over the long term. You may vote once every thirty days.

Log in to vote on this brokerage.
COMMUNITY RATINGS
0.0out of 5 (last 90 days)
0 of 5 stars
OUTPERFORM VOTES
0 Believe will outperform the market
UNDERPERFORM VOTES
0 Believe will underperform the market

Guggenheim's equity research team has issued ratings on 406 companies across 11 sectors over the past 12 months, covered by 34 analysts. The Guggenheim analysts below are listed by number of ratings issued in the last year.

Guggenheim Stock Coverage by Sector

Guggenheim concentrates its research most heavily in Healthcare (45.2%), Consumer Discretionary (17.1%) and Technology (12.0%). The chart below shows how Guggenheim's 416 rated companies are distributed across all 11 sectors it covers.

Guggenheim - Frequently Asked Questions

Guggenheim's analysts currently have buy-equivalent ratings on 346 companies. Recent upgrades to buy include Entera Bio, Editas Medicine, New York Times, Sensei Biotherapeutics and Applied Aerospace & Defense.

Guggenheim's highest-rated analysts by MarketBeat's accuracy score include Seamus Fernandez, Subbu Nambi and Yatin Suneja. Rankings are based on historical rating accuracy and price target precision over the past 12 months. MarketBeat tracks 39 analysts at Guggenheim.

Guggenheim has the deepest coverage in Healthcare (45.2% of rated companies), Consumer Discretionary (17.1% of rated companies), Technology (12.0% of rated companies), Industrials (10.6% of rated companies) and Communication Services (8.2% of rated companies).

Guggenheim issued 1,209 ratings over the last 12 months across 416 companies — an average of roughly 101 rating actions per month. These include boost price target, downgrade, initiated coverage, lower price target, reiterated rating, set price target and upgrade. MarketBeat tracks every rating change as it's published so you can see the most current Guggenheim analyst actions.

A buy rating indicates the analyst expects the stock to outperform the market over the next 12 months. A hold suggests the stock will perform in line with the market. A sell rating indicates expected underperformance. Guggenheim uses Buy, Neutral, and Sell as their equivalents.